about
Clinical Advancements in the Targeted Therapies against Liver Fibrosis.The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells.Target Therapy in Hematological Malignances: New Monoclonal Antibodies.High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer.
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Monoclonal antibodies in targeted therapy
@ast
Monoclonal antibodies in targeted therapy
@en
Monoclonal antibodies in targeted therapy
@nl
type
label
Monoclonal antibodies in targeted therapy
@ast
Monoclonal antibodies in targeted therapy
@en
Monoclonal antibodies in targeted therapy
@nl
prefLabel
Monoclonal antibodies in targeted therapy
@ast
Monoclonal antibodies in targeted therapy
@en
Monoclonal antibodies in targeted therapy
@nl
P2093
P356
P1476
Monoclonal antibodies in targeted therapy
@en
P2093
Beata Powroźnik
Elżbieta Pękala
Paulina Kubowicz
P304
P356
10.5604/17322693.1009980
P407
P577
2012-09-12T00:00:00Z